Fevertree Drinks (FEVR) Stock Overview
Engages in the development and sale of mixer drinks in the United Kingdom, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for FEVR from our risk checks.
FEVR Community Fair Values
Create NarrativeSee what 35 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Fevertree Drinks PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£8.48 |
| 52 Week High | UK£9.80 |
| 52 Week Low | UK£7.11 |
| Beta | 1.14 |
| 1 Month Change | 5.94% |
| 3 Month Change | 3.61% |
| 1 Year Change | -10.51% |
| 3 Year Change | -36.99% |
| 5 Year Change | -64.27% |
| Change since IPO | 413.64% |
Recent News & Updates
FEVR: Reduced Rating And Elevated Multiple Will Limit Future Upside
Analysts have trimmed their price target on Fevertree Drinks to £7.80 from £9.20, reflecting updated views on fair value, growth, margins and an adjusted future P/E assumption. What’s in the News for Fevertree Drinks Fevertree Drinks announced a change in its equity buyback plan terms on June 9, 2026, increasing its existing authorization by an additional £30 million.FEVR: Higher Fair Value Will Reflect Reset P/E Expectations Over Time
Analysts have trimmed their price targets for Fevertree Drinks to around £7.80, down from about £9.20, as they factor in updated assumptions for revenue growth, profit margins and future P/E expectations. Analyst Commentary Recent research suggests that while price targets have eased to around £7.80, some analysts still see room for upside if Fevertree executes well on its plans.FEVR: Higher Fair Value Will Reflect Improved Margin And Future P/E Expectations
Analysts have made a small upward adjustment to the implied fair value for Fevertree Drinks to about £13.66 per share, reflecting a mix of reduced and raised Street price targets and updated assumptions around revenue growth, profit margins and future P/E expectations. Analyst Commentary Recent Street research on Fevertree Drinks has been mixed, with some analysts trimming price targets and others lifting them.Recent updates
Shareholder Returns
| FEVR | GB Beverage | GB Market | |
|---|---|---|---|
| 7D | -0.06% | -1.9% | 0.03% |
| 1Y | -10.5% | -4.3% | 18.4% |
Return vs Industry: FEVR underperformed the UK Beverage industry which returned -0.9% over the past year.
Return vs Market: FEVR underperformed the UK Market which returned 18.7% over the past year.
Price Volatility
| FEVR volatility | |
|---|---|
| FEVR Average Weekly Movement | 3.9% |
| Beverage Industry Average Movement | 3.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: FEVR has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: FEVR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 285 | Tim Warrillow | fever-tree.com |
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company offers tonics, soft drinks, non-alcoholic, sodas, gingers, ready to drink, cocktail mixers, and cola and lemonades. It sells its products under the Fever-Tree brand name.
Fevertree Drinks PLC Fundamentals Summary
| FEVR fundamental statistics | |
|---|---|
| Market cap | UK£953.90m |
| Earnings (TTM) | UK£22.60m |
| Revenue (TTM) | UK£325.00m |
Is FEVR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FEVR income statement (TTM) | |
|---|---|
| Revenue | UK£325.00m |
| Cost of Revenue | UK£210.50m |
| Gross Profit | UK£114.50m |
| Other Expenses | UK£91.90m |
| Earnings | UK£22.60m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Sep 10, 2026
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 35.23% |
| Net Profit Margin | 6.95% |
| Debt/Equity Ratio | 0% |
How did FEVR perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/04 05:26 |
| End of Day Share Price | 2026/08/03 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fevertree Drinks PLC is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ewan Mitchell | Barclays |
| Ashutosh Jain | Barclays |
| Mandeep Sangha | Barclays |